Pasireotide therapy of Multiple Endocrine Neoplasia type 1 (MEN1)-associated neuroendocrine tumours (NETs) improves survival and reduces tumour progression in a Men1+/- mouse model
The OCDEM Friday Seminar Series is supported by an unrestricted educational grant from the Boehringer-Ingelheim and Eli Lilly Alliance
Date:
15 January 2016, 12:45
Venue:
Churchill OCDEM 1, Headington OX3 7LE
Venue Details:
Robert Turner Lecture Theatre
Speaker:
Dr Mark Stevenson
Organising department:
Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
Organiser:
OCDEM Senior Academic Faculty (SAF)
Part of:
OCDEM Friday Seminar Series
Topics:
Booking required?:
Not required
Audience:
Members of the University only
Editors:
Sarah Cross,
Matthew Simmonds
